TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Gross margin 2023–2025
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) gross margin by fiscal year — reported gross profit divided by reported revenue.
49.3%FY2025 · since FY2023: 39.0% → 49.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 49.3% | +26.3 pp |
| FY2024 | 23.1% | -15.9 pp |
| FY2023 | 39.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TNXP financial trends
TNXP RevenueTNXP Net incomeTNXP Net marginTNXP Gross profitTNXP Operating incomeTNXP Operating marginTNXP Operating cash flowTNXP Free cash flowTNXP Capital expendituresTNXP Return on equityTNXP Stock buybacksTNXP Dividends paidTNXP Total assetsTNXP Total liabilitiesTNXP Shareholders’ equityTNXP overview →